Factors affecting the stability and conformation of Locusta migratoria apolipophorin III.
Apolipophorin III (apoLp-III) from the migratory locust, Locusta migratoria, represents the only full-length apolipoprotein whose three-dimensional structure has been solved. In the present study, spectroscopic methods have been employed to investigate the effects of deglycosylation (via endoglycosidase F treatment) and complexation with lipid on the stability and conformation of this protein. Addition of isolated lipid-free apoLp-III to sonicated vesicles of dimyristoylphosphatidylcholine (DMPC) resulted in the formation of relatively uniform disklike complexes with an average Strokes diameter of 13.5 nm. Flotation equilibrium experiments conducted in the analytical ultracentrifuge revealed a particle molecular mass of 588 500 Da. Chemical cross-linking and compositional analysis of apoLp-III.DMPC complexes indicated five apoLp-III molecules per disk and an overall DMPC:apoLp-III molar ratio of 122:1. Circular dichroism (CD) spectra of apoLp-III samples suggested a loss of alpha-helical structure upon deglycosylation, while complexation with DMPC did not significantly alter the helix content (estimated to be > 75%). Fluorescence spectroscopy revealed that the apoLp-III tryptophan fluorescence emission maximum was blue-shifted from 347 to 332 and 321 nm upon deglycosylation and complexation with DMPC, respectively. In quenching experiments with native apoLp-III, tryptophan residues were shielded from the positively charged quencher, CsCl. Increased exposure to KI, CsCl, and acrylamide was observed upon deglycosylation, whereas complexation with DMPC yielded lower Ksv values for KI and acrylamide and an increased value for CsCl versus native lipid-free apoLp-III. In guanidine hydrochloride denaturation studies monitored by CD or fluorescence, native, lipid-free apoLp-III displayed a denaturation midpoint of 0.60 M, and delta GDH2O = 5.37 kcal/mol was calculated.(ABSTRACT TRUNCATED AT 250 WORDS)
Weers
P M
PM
MRC Group in Protein Structure and Function, University of Alberta, Edmonton, Canada.
Kay
C M
CM
Oikawa
K
K
Wientzek
M
M
Van der Horst
D J
DJ
Ryan
R O
RO
D020106:Acrylamide; D000178:Acrylamides / Q000494:pharmacology; D000818:Animals; D001053:Apolipoproteins / Q000737:chemistry* / Q000378:metabolism; D002021:Buffers; D002586:Cesium / Q000494:pharmacology; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D002712:Chlorides / Q000494:pharmacology; D002942:Circular Dichroism; D003432:Cross-Linking Reagents; D004134:Dimyristoylphosphatidylcholine / Q000378:metabolism; D004355:Drug Stability; D006031:Glycosylation; D006110:Grasshoppers; D006863:Hydrogen-Ion Concentration; D008081:Liposomes / Q000378:metabolism; D008970:Molecular Weight; D011193:Potassium Iodide / Q000494:pharmacology; D011487:Protein Conformation; D011489:Protein Denaturation; D017433:Protein Structure, Secondary; D013050:Spectrometry, Fluorescence
D000178:Acrylamides; D001053:Apolipoproteins; D002021:Buffers; D002712:Chlorides; D003432:Cross-Linking Reagents; D008081:Liposomes; C042470:apolipophorin III; D011193:Potassium Iodide; D002586:Cesium; D020106:Acrylamide; C028019:cesium chloride; D004134:Dimyristoylphosphatidylcholine